He Huang
First Affiliated Hospital of Zhejiang University · The Second Affiliated Hospital, Chongqing Medical University · Zhejiang University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name He Huang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:27 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07257640 · IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic LeukemiaZhejiang University · recruiting · Hematologic Diseases, Neoplasms · principal investigator
- Ph1NCT07246707 · KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaZhejiang University · recruiting · B-ALL · principal investigator
- Early Ph1NCT07144020 · Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid LeukemiaZhejiang University · recruiting · Acute Myeloid Leukemia · principal investigator
- N/ANCT06838572 · Effect of Remote Local Peripheral Nerve Cooling on Pain of Arterial PunctureThe Second Affiliated Hospital of Chongqing Medical University · recruiting · Acute Pain · study chair
- Early Ph1NCT06793241 · Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaZhejiang University · recruiting · B-cell Acute Lymphoblastic Leukemia · principal investigator
- Early Ph1NCT06787560 · CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System DiseasesZhejiang University · recruiting · Bone Marrow Failure Syndrome · principal investigator
- Early Ph1NCT06785519 · CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus NephritisHe Huang · recruiting · Lupus Nephritis · principal investigator
- Early Ph1NCT06769191 · Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIODZhejiang University · recruiting · Schimke Immuno-osseous Dysplasia · principal investigator
- Early Ph1NCT06762132 · A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid LeukemiaZhejiang University · recruiting · Acute Myeloid Leukemia · principal investigator
- Ph1NCT06750133 · Universal CNK-UT Therapy for Refractory aGVHDFirst Affiliated Hospital of Zhejiang University · recruiting · Acute Graft-versus-Host Disease · principal investigator
- Early Ph1NCT06633354 · Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALLZhejiang University · recruiting · T-Acute Lymphoblastic Leukemia · principal investigator
- Early Ph1NCT06633328 · CD7 CAR-T Bridging to alloHSCT for Severe Aplastic AnemiaZhejiang University · recruiting · Aplastic Anemia · principal investigator
- Early Ph1NCT06633341 · Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphomaZhejiang University · recruiting · T-lymphoblastic Lymphoma · principal investigator
- Ph4NCT06569953 · Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical TrialThe Second Affiliated Hospital of Chongqing Medical University · recruiting · Acute Pain, Chronic Pain, Postoperative Pain · study chair
- N/ANCT06452186 · Restoration of Normative Postural ControlNorth Carolina State University · recruiting · Lower Limb Amputation Below Knee (Injury) · principal investigator
- Ph1NCT06367673 · Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid LeukemiaZhejiang University · unknown · AML, Adult · principal investigator
- Early Ph1NCT06346912 · CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHLZhejiang University · recruiting · Acute Lymphoblastic Leukemia,B-Cell, Non-hodgkin Lymphoma,B Cell · principal investigator
- Early Ph1NCT06279923 · CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune DiseasesZhejiang University · recruiting · Autoimmune Diseases · principal investigator
- N/ANCT06281431 · A Comparative Effect of Echogenic Needle for Nerve Block on Acute and Chronic Postoperative PainThe Second Affiliated Hospital of Chongqing Medical University · unknown · Chronic Postoperative Pain · study chair
- N/ANCT06165757 · The Effects of Non Harmonic and White Noise on Human Pain Sensitivity: a Study of Healthy VolunteersThe Second Affiliated Hospital of Chongqing Medical University · completed · Pain · principal investigator
- N/ANCT06130436 · Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing HepatectomyThe Second Affiliated Hospital of Chongqing Medical University · completed · Hepatic Hemangioma, Liver Cancer, Hepatolithiasis · study chair
- Early Ph1NCT06119659 · Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001Zhejiang University · unknown · Hemophilia B Without Inhibitor · principal investigator
- Ph1/Ph2NCT06118788 · Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaGuangzhou Bio-gene Technology Co., Ltd · recruiting · Leukemia, Myeloid, Acute · principal investigator
- Ph1NCT06084962 · A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple MyelomaHe Huang · unknown · Relapse/Refractory Multiple Myeloma · principal investigator
- Ph1/Ph2NCT06052813 · A Study of BN104 in the Treatment of Acute LeukemiaInstitut de Recherches Internationales Servier (I.R.I.S.) · active not recruiting · ALL, Adult, AML, Adult, Acute Leukaemia · principal investigator
- Ph1NCT06027853 · Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid LeukemiaZhejiang University · unknown · AML, Adult · principal investigator
- N/ANCT06018246 · Nutritional Risk Screening Nutritional Support Gastrointestinal CancerThe First Affiliated Hospital of Shanxi Medical University · completed · Gastrointestinal Cancer · study director
- Ph1NCT05846347 · Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus ErythematosusZhejiang University · unknown · CAR-T · principal investigator
- Ph1NCT05828212 · Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis OpticaZhejiang University · completed · Neuromyelitis Optica · principal investigator
- Ph1/Ph2NCT05827835 · CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic DiseasesZhejiang University · recruiting · Hematologic Diseases, Neoplasms · principal investigator
- Ph1NCT05828225 · Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia GravisZhejiang University · unknown · Myasthenia Gravis · principal investigator
- Ph1NCT05740891 · AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple MyelomaZhejiang University · unknown · Multiple Myeloma · principal investigator
- Ph1NCT05731219 · UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · Relapsed/Refractory Acute Myeloid Leukemia · principal investigator
- Ph2NCT05712083 · A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple MyelomaZhejiang University · unknown · Multiple Myeloma, New Diagnosis Tumor · principal investigator
- N/ANCT05529212 · Cardiac Surgery and Postoperative Organ DysfunctionThe Second Affiliated Hospital of Chongqing Medical University · unknown · Postoperative Complications · principal investigator
- Ph1NCT05473221 · Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- Ph1NCT05467254 · Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- Ph1NCT05467202 · Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- Ph1NCT05463640 · Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- N/ANCT05392426 · Left Ventricular Global Longitudinal Strain and Postoperative Myocardial InjuryThe Second Affiliated Hospital of Chongqing Medical University · unknown · Postoperative Complications · principal investigator
- Ph1NCT05379647 · Natural Killer (NK) Cell Therapy for B-Cell MalignanciesZhejiang University · unknown · B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia · principal investigator
- N/ANCT05356520 · Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric JunctionXijing Hospital of Digestive Diseases · recruiting · Siewert Type II Adenocarcinoma of Esophagogastric Junction · principal investigator
- Ph1NCT05350852 · Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALLZhejiang University · unknown · B-ALL · principal investigator
- Ph1NCT05350787 · Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALLZhejiang University · completed · B-ALL · principal investigator
- Ph1NCT05349266 · Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) TherapyZhejiang University · unknown · Non-Hodgkin's Lymphoma · principal investigator
- Ph1NCT05340829 · Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/LympholeukemiaHe Huang · unknown · AIDS Related Lymphoma and Lympholeukemia · principal investigator
- Ph4NCT05331651 · Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and VomitingThe Second Affiliated Hospital of Chongqing Medical University · completed · Postoperative Nausea and Vomiting · principal investigator
- Early Ph1NCT05263817 · A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and VasculitisZhejiang University · unknown · POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia · principal investigator
- Ph4NCT05265507 · Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and OndansetronThe Second Affiliated Hospital of Chongqing Medical University · unknown · Postoperative Nausea and Vomiting · principal investigator
- Early Ph1NCT05252572 · Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological MalignanciesZhejiang University · unknown · AML · principal investigator
- Early Ph1NCT05239689 · Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological MalignanciesZhejiang University · unknown · AML · principal investigator
- Early Ph1NCT05239676 · Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant LymphomaZhejiang University · unknown · Lymphoma · principal investigator
- Early Ph1NCT05239702 · Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune DiseasesZhejiang University · unknown · Crohn Disease, Ulcerative Colitis, Dermatomyositis · principal investigator
- Ph1NCT05170568 · PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesPersonGen BioTherapeutics (Suzhou) Co., Ltd. · unknown · CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies · principal investigator
- Early Ph1NCT05085418 · A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune NephritisZhejiang University · unknown · Immune Nephritis, Autoimmune Diseases, Lupus Nephritis · principal investigator
- Early Ph1NCT05085444 · A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory SclerodermaZhejiang University · unknown · Scleroderma, Autoimmune Diseases · principal investigator
- Early Ph1NCT05085431 · A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's SyndromeZhejiang University · unknown · Sjogren's Syndrome, Autoimmune Diseases · principal investigator
- Early Ph1NCT05030779 · A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus ErythematosusZhejiang University · unknown · Systemic Lupus Erythematosus, Autoimmune Diseases · principal investigator
- Ph1NCT04516551 · Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCTXinqiao Hospital of Chongqing · unknown · Relapsed Adult ALL, B Cell Leukemia · principal investigator
- N/ANCT04213469 · PD1-CD19-CART in Patients With r/r B-cell LymphomaBioray Laboratories · completed · B-cell Lymphoma · principal investigator
- N/ANCT03229876 · Safety and Efficacy Evaluation of CD19-UCARTBioray Laboratories · suspended · Acute Lymphoblastic Leukemia (ALL), Non Hodgkin Lymphoma (NHL) · principal investigator
- Ph1/Ph2NCT03118180 · CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell LymphomaZhejiang University · unknown · Lymphoma · principal investigator
- N/ANCT02813837 · Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic MalignanciesInnovative Cellular Therapeutics Co., Ltd. · unknown · Leukemia, B-Cell, Lymphoma, B-Cell · study director
- Ph2NCT02098629 · Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial InfarctionShantou University Medical College · completed · Myocardial Reperfusion Injury · study director
- Ph2/Ph3NCT01526850 · Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host DiseaseChinese Academy of Medical Sciences · unknown · Chronic Graft Versus Host Disease · principal investigator
- Ph4NCT01198236 · Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal InfectionZhejiang University · completed · Invasive Fungal Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 73 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- New role of NP Exoribonuclease in Lassa virus infectionR01AI187204 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2025 to 2026 · $543,436 awarded in 2026Same name and institution; not confirmed by an ID
- Toward Restoration of Normative Postural Control and Stability using Neural Control of Powered Prosthetic AnklesR01HD110519 · NICHD · NORTH CAROLINA STATE UNIVERSITY RALEIGH · fiscal years 2023 to 2026 · $619,693 awarded in 2026Same name and institution; not confirmed by an ID
- Towards Efficient Personalization of Computerized Lower Limb Prostheses via Reinforcement Learning in a Clinical SetupR01HD116422 · NICHD · NORTH CAROLINA STATE UNIVERSITY RALEIGH · fiscal years 2025 to 2026 · $602,405 awarded in 2026Same name and institution; not confirmed by an ID
- Novel Function(s) of Arenavirus NP ExoribonucleaseR21AI166985 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2022 to 2023 · $200,000 awarded in 2023Same name and institution; not confirmed by an ID
- Error Tolerance in Wearer-Robot SystemsR01EB024570 · NIBIB · NORTH CAROLINA STATE UNIVERSITY RALEIGH · fiscal years 2018 to 2022 · $430,972 awarded in 2022Same name and institution; not confirmed by an ID
- Molecular Mechanisms of Regulation of Bone Remodeling and Orthodontic Tooth Movement by Vascular Endothelial Growth FactorR15DE027217 · NIDCR · STATE UNIVERSITY NEW YORK STONY BROOK · fiscal years 2017 · $458,420 awarded in 2017Same name and institution; not confirmed by an ID
- Selenium-Derivatized RNAs and DNAs for High-Throughput Protein/Nucleic Acid CrystR01GM095881 · NIGMS · GEORGIA STATE UNIVERSITY · fiscal years 2012 to 2016 · $281,200 awarded in 2016Same name and institution; not confirmed by an ID
- IMMUNIZATION AND VACCINES FOR CHILDREN GRANTSH23IP122558 · NCIRD · MAINE STATE DEPT/HEALTH/HUMAN SERVS · fiscal years 2002 to 2012 · $2,935,048 awarded in 2012Same name and institution; not confirmed by an ID
- Bacillus anthracis Detection with RNA MicrochipR21AI058051 · NIAID · GEORGIA STATE UNIVERSITY · fiscal years 2005 to 2006 · $141,104 awarded in 2006Same name and institution; not confirmed by an ID
- SELECTIVE CHARGE DERIVATIZATION USE IN PSD MALDI TOF MS PEPTIDE SEQUENCINGP41RR000480 · NCRR · MICHIGAN STATE UNIVERSITY · fiscal years 1997 · $4,586 awarded in 1997Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:27 UTC. The ranking covers the 200 most relevant of 1143 PubMed records, and a shared surname and initials can bring in a namesake. All 1143 on PubMed
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med · 20203,522 citationsRCR 201.4
- 546 citationsRCR 18.6
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.J Clin Oncol · 2019390 citationsRCR 15.7
- 386 citationsRCR 15.7
- Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.N Engl J Med · 2015322 citationsRCR 9.1
- Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).J Clin Oncol · 2020292 citationsRCR 13.5
- Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.N Engl J Med · 2019247 citationsRCR 10.4
- Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial.Lancet Gastroenterol Hepatol · 2021230 citationsRCR 17.0
- Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.N Engl J Med · 2015220 citationsRCR 10.5
- 205 citationsRCR 13.3